跳至主要内容
临床试验/NCT02306031
NCT02306031Unknown2 期

The Effect of Topical Sodium Diclofenac on Macular Thickness in Diabetic Eyes After Phacoemulsification: A Randomized Controlled Trial

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
108
试验地点
1
主要终点
macular thickness changes

研究概览

简要总结

Eyes of 108 diabetic patients have underwent phacoemulsification and intraocular lens implantation surgery have enrolled. Fifty four eyes have received the conventional postoperative care with steroid drop, whereas the other group (54 eyes) have given a preoperative diclofenac drop four times daily in addition to steroid drop and continued six weeks after surgery. All patients have evaluated by Optical coherence tomography (OCT) preoperatively and days 1, 30, and 90.The outcome measures including best corrected visual acuity (BCVA) and OCT findings were compared in and between both groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Diabetic patients with non-proliferative diabetic retinopathy that were candidate for phacoemulsification and intraocular lens implantation

排除标准

  • Eyes with clinically significant macular edema based on the ETDRS(Early Treatment Diabetic Retinopathy Study) study and/or central macular thickness >260µ were not included. Neither did we include the eyes with other accompanying diseases affecting the macula or eyes with history of previous retinal laser photocoagulation or intraocular surgery.
  • Eyes with severe cataract that preclude performing an acceptable quality optical coherence tomography (OCT) were not enrolled either.

研究组 & 干预措施

placebo (ARTIFICIAL TEAR)

Placebo Comparator

control group received artificial tear (Sina Darou Laboratories Company, Tehran, Iran) as a placebo every 6 hours. Theses drops continued up to 6 weeks with the same dose after operations.

干预措施: Prescribe ARTIFICIAL TEAR (Drug)

diclofenac sodium drop

Active Comparator

case group received diclofenac sodium drop 0.1% (Sina Darou Laboratories Company, Tehran, Iran) every 6 hours.. Theses drops continued up to 6 weeks with the same dose after operations.

干预措施: Prescribe diclofenac sodium drop 0.1% (Drug)

结局指标

主要结局

macular thickness changes

时间窗: preoperatively until 90 days

Optical coherence tomography (OCT)

次要结局

  • best corrected visual acuity (BCVA) changes(preoperatively until 90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zahra Rabbani Khah

Clinical Professor, Ophthalmic Research Center

Shahid Beheshti University of Medical Sciences

研究点 (1)

Loading locations...

相似试验